1-855-378-42281-855-378-4228
One of the out-patient rehabilitation options for people in Henderson who are struggling with opioid dependence and addiction is called opioid maintenance therapy. Some facilities and doctors are certified to give specific meds to opioid dependent individuals, many of which are opioids themselves and are addiction. In low enough doses the user doesn't experience being high and also does not experience acute cravings and isn't experiencing opioid withdrawal. Methadone is the first drug administered for this purpose, but there are other choices currently to select from.
Methadone is an opioid and is meant to be taken at an out-patient medical center certified to dispense the med, which is taken on a daily basis in liquid or pill form. The cost of the drug is about one hundred and fifty dolloars a month. Buprenorphine is also an opioid-based drug, and is a pill often taken every other day. But different from Methadone that is only be dispensed in well-regulated clinics, Buprenorphine can be prescribed and administered in doctor's offices. The monthly cost of buprenorphine is about three hundred dollars per month for the generic of the med. There is also a type of buprenorphine that contains naloxone, which is a drug which blocks the effects of opiates. A person taking this formulation, AKA Suboxone, would find it more difficult to feel high from opioids if they relapsed while taking the drug. It is also taken every day, and is priced approximately $450 /month. Naltrexone is an additional medication used in opioid maintenance therapy, but unlike the other drugs mentioned it is an opioid blocker and is not an opioid. A person has the choice to take this medication as a monthly shot, which is called Vivitrol. As an opioid blocker, it prevents an individual from experience being high from opioids, and therefore lowers the risk associated with relapse. This daily injection costs in the range of $1000 to $1200 monthly.
For All Alcohol and Drug Rehabilitation Facilities In Henderson, Click Here.
